| |
| |
|
| Insider
Information: |
Daruwala Paul |
| Relationship: |
Chief Operating Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
221,099 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
221,099 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cidara Therapeutics, Inc. |
CDTX |
Chief Operating Officer |
2022-09-12 |
221,099 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-09-12 |
4 |
S |
$0.68 |
$11,095 |
D/D |
(16,199) |
221,099 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
237,298 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2022-01-05 |
4 |
S |
$1.25 |
$6,416 |
D/D |
(5,133) |
187,298 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,900 |
192,431 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
132,000 |
182,531 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2020-01-03 |
4/A |
S |
$3.42 |
$3,215 |
D/D |
(940) |
52,592 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2020-01-03 |
4 |
S |
$3.42 |
$8,003 |
D/D |
(2,340) |
53,532 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2019-10-02 |
4 |
S |
$1.88 |
$6,195 |
D/D |
(3,295) |
55,872 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2019-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,600 |
59,167 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2019-03-07 |
4 |
S |
$2.55 |
$5,714 |
D/D |
(2,240) |
49,567 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2019-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
51,807 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Commercial Officer |
• – – |
2017-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
45,807 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Medical OfficerOfficer |
• – – |
2015-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
101,435 |
|
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
Chief Commercial OfficerOffice |
• – – |
2015-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,807 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
